Abstract
In this thesis, we explored electronically-controlled needle-free jet injection-assisted dermal drug delivery of bleomycin as a novel treatment for keloid scars that could potentially lead to a high skin bioavailability, better patient satisfaction, and, ultimately, in higher clinical effectiveness compared to conventional hypodermic needle injections.
Original language | English |
---|---|
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 25 May 2022 |
Place of Publication | Rotterdam |
Publication status | Published - 25 May 2022 |